Many experimental approaches rely on controlling gene expression in select subsets of 18 cells within an individual animal. However, reproducibly targeting transgene expression 19 to specific fractions of a genetically-defined cell-type is challenging. We developed 20
effectors and apply these tools to calcium imaging of individual neurons and optogenetic 24 manipulation of sparse cell populations in vivo. 25
Main Text 26
Genetic labeling and manipulation of small groups of cells in somatic mosaic 27 animals have provided significant insights into many aspects of biology and have been 28 particularly impactful in studies of the nervous system. Indeed, measurement and 29 manipulation of genetically defined cell types has become central to neural circuit 30 dissection in many systems 1 . Especially powerful are paradigms in which one measures 31 the phenotypes of stochastically selected individual cells within otherwise 32 unmanipulated populations. However, few methods exist for selectively manipulating a 33 desired fraction of cells of the same genetically-defined type. In rodents, sequential 34 recombinase-mediated switches can label subpopulations of neurons, but require labor-35 intensive titration of viruses 2 . In Drosophila, GAL4 and split GAL4 lines enable targeting 36 of single cell types 3 , but selective manipulation of subsets of neurons of the same type 37 remains challenging. For example, effector expression can be restricted by limiting the 38 spatial and/or temporal expression of a recombinase, but this necessitates user-39 dependent heat shock or chemical induction, and in some cases, cannot be used in 40 post-mitotic cells 4-6 . Therefore, a routine all-genetic method of expressing effectors in 41 defined fractions of post-mitotic cells of the same type would provide a powerful means 42 of dissecting cellular and genetic functions. 43
To address this need, we developed SPARC, a toolkit to express any effector in 44 precise proportions of post-mitotic cells labelled by the GAL4-UAS system ( Fig. 1A , S1, sequences. We designed each UAS-driven construct, so that PhiC31 recombinase 8 48 could irreversibly recombine one of two competing attP target sequences with one attB 49 target sequence. The reaction mediated by the first attP would remove a stop cassette 50 to enable effector expression in cells expressing Gal4, while the reaction using the 51 second attP would leave this stop intact and prevent expression ( Fig. S1 ). Truncating 52 canonical attP sequences diminishes the efficacy of recombination in vitro 9 . Based on 53 this, we reasoned that truncating the first attP relative to the second would shift the 54 equilibrium to favor retention of the stop cassette and result in sparser effector 55
To test this concept, we generated plasmids and transgenic flies bearing SPARC 57 constructs expressing the calcium indicator GCaMP6f 10 and including one of three 58 different attP variants at the first position (canonical: attP60; truncated: attp38 or 59 attp34) 9 . We also generated transgenic flies that express PhiC31 recombinase in all 60 post-mitotic neurons under the control of the synaptobrevin promoter 3 . We then drove 61 (Dense), SPARC-I (Intermediate), and SPARC-S (Sparse). To determine the 69 percentage of these neurons labeled by each SPARC module, we expressed 70 myristoylated-tdTomato (myr-tdT) in all T4 and T5 neurons in parallel with SPARC-71
GCaMP6f and counted singly and doubly labeled T4 and T5 cell bodies ( Fig. 1F and 72 S3). For SPARC-D-GCaMP6f we observed effector expression in ~45% of T4 and T5 73 neurons. In comparison, SPARC-I-GCaMP6f labeled ~12% of T4 and T5 neurons, while 74 SPARC-S-GCaMP6f labeled only ~4% of these neurons. We observed similar results in 75
Kenyon cells, Lobula-Columnar neurons, and several columnar neurons in the optic 76 lobe ( Fig. S4 and data not shown). These data demonstrate that the SPARC module 77 can reproducibly determine the fraction of cells that express effector over a more than 78 10-fold range across cells and animals. As SPARC-S can readily label T4, T5 and 79 Kenyon cells, very common cell types in the fly brain, these studies argue that one of 80 the three SPARC modules should allow targeting of individual cells of any cell type of 81
interest. 82
To generalize this technique, we next made SPARC-LexA::p65 transgenes. 83
LexA::p65 is a transcription factor that drives expression of transgenes under the control 84 of the lexAop promoter 12 ; this system is orthogonal to the UAS-GAL4 expression 85 system. We expressed SPARC-LexA::p65 in Mi1 neurons of the Drosophila optic lobe 86 ( Fig 1B) , and found that in the absence of PhiC31 recombinase, SPARC-LexA::p65 87 labels 100% of these neurons with lexAop-myr-tdT ( Fig. 1G -G''). This result suggested 88 that the widely-used stop cassette 13 that we used in the initial SPARC design might 89 permit a low level of read-through that can be detected by sensitive outputs like self-cleaving ribozymes from the Hepatitis Delta Virus (HDV) into the SPARC module 93 ( Fig. 1A ). We reasoned that these self-cleaving ribozymes should truncate any read-94 through transcript prior to translation 14,15 . We first examined SPARC2-LexA::p65 95 Next, to investigate the functional utility of SPARC, we first used SPARC-S-104
GCaMP6f to image calcium (Ca 2+ ) response in the dendrites of individual T5 neurons. 105
These neurons preferentially respond to visual motion in one direction, a direction 106 selectivity that is first observed in their dendrites 16 . Previous attempts to image from 107 6 significantly more direction selective than those from FlpOut-labeled ROIs (DSI; Fig. 2C -115 E). This result reflects the fact that SPARC labeling was sparser than the sparsest 116
FlpOut labeling we could achieve. As a consequence, SPARC ROIs more nearly 117 captured signals from single cells, while FlpOut ROIs likely included signals from 118 multiple labeled cells with different directional preferences (see supplemental methods). 119
Thus, both anatomical and functional evidence suggests that SPARC better isolates 120 single T5 dendrites more easily and more consistently than standard FlpOut 121
approaches. 122
Then, to determine if we could use this approach to manipulate the activity of 123 neuronal subpopulations, we generated SPARC2-CsChrimson::tdTomato 19 transgenic 124 flies. We expressed this construct in Ring (R) neurons, GABAergic neurons that send 125 sensory input to the central complex 20 . R neurons are divided into types based on 126 morphology 21 , here we focused on the R2 type. We expressed SPARC2-D-127
CsChrimson::tdTomato in a subset of R2 neurons ( Figures 2F-H" ). We observed that 128 tdTomato + R2 neurons were depolarized by light, while tdTomato -R2 neurons were not 129 optogenetically modulate neuronal activity (CsChrimson). In addition, the availability of allowing users to easily incorporate any current or future genetically encoded effector 149 ( Fig. S3 ). In the context of the nervous system, SPARC, SPARC2 and future variations 150 will allow convenient and unparalleled access to define the heterogeneity of single 151 neuron contributions to neural circuit processing. In non-neuronal cells, SPARC will 152 enable wide-ranging studies that exploit mosaic analysis to investigate the cell biology 153 and physiology of post-mitotic cells. Finally, as PhiC31 functions in both the mouse and 154 fish 22,23 , we anticipate that this strategy will be widely generalizable to other model 155
systems. 156
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